Product Details for ANDA 090879
RIVASTIGMINE TARTRATE (RIVASTIGMINE TARTRATE)
EQ 1.5MG BASE
Marketing Status: Prescription
EQ 3MG BASE
Marketing Status: Prescription
EQ 4.5MG BASE
Marketing Status: Prescription
EQ 6MG BASE
Marketing Status: Prescription
EQ 1.5MG BASE
Marketing Status: Prescription
Active Ingredient: RIVASTIGMINE TARTRATE
Proprietary Name: RIVASTIGMINE TARTRATE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 1.5MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A090879
Product Number: 001
Approval Date: Jun 10, 2015
Applicant Holder Full Name: ORBION PHARMACEUTICALS PRIVATE LTD
Marketing Status: Prescription
Patent and Exclusivity Information
RIVASTIGMINE TARTRATE (RIVASTIGMINE TARTRATE)
Proprietary Name: RIVASTIGMINE TARTRATE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 1.5MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A090879
Product Number: 001
Approval Date: Jun 10, 2015
Applicant Holder Full Name: ORBION PHARMACEUTICALS PRIVATE LTD
Marketing Status: Prescription
Patent and Exclusivity Information
EQ 3MG BASE
Marketing Status: Prescription
Active Ingredient: RIVASTIGMINE TARTRATE
Proprietary Name: RIVASTIGMINE TARTRATE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 3MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A090879
Product Number: 002
Approval Date: Jun 10, 2015
Applicant Holder Full Name: ORBION PHARMACEUTICALS PRIVATE LTD
Marketing Status: Prescription
Patent and Exclusivity Information
RIVASTIGMINE TARTRATE (RIVASTIGMINE TARTRATE)
Proprietary Name: RIVASTIGMINE TARTRATE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 3MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A090879
Product Number: 002
Approval Date: Jun 10, 2015
Applicant Holder Full Name: ORBION PHARMACEUTICALS PRIVATE LTD
Marketing Status: Prescription
Patent and Exclusivity Information
EQ 4.5MG BASE
Marketing Status: Prescription
Active Ingredient: RIVASTIGMINE TARTRATE
Proprietary Name: RIVASTIGMINE TARTRATE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 4.5MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A090879
Product Number: 003
Approval Date: Jun 10, 2015
Applicant Holder Full Name: ORBION PHARMACEUTICALS PRIVATE LTD
Marketing Status: Prescription
Patent and Exclusivity Information
RIVASTIGMINE TARTRATE (RIVASTIGMINE TARTRATE)
Proprietary Name: RIVASTIGMINE TARTRATE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 4.5MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A090879
Product Number: 003
Approval Date: Jun 10, 2015
Applicant Holder Full Name: ORBION PHARMACEUTICALS PRIVATE LTD
Marketing Status: Prescription
Patent and Exclusivity Information
EQ 6MG BASE
Marketing Status: Prescription
Active Ingredient: RIVASTIGMINE TARTRATE
Proprietary Name: RIVASTIGMINE TARTRATE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 6MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A090879
Product Number: 004
Approval Date: Jun 10, 2015
Applicant Holder Full Name: ORBION PHARMACEUTICALS PRIVATE LTD
Marketing Status: Prescription
Patent and Exclusivity Information
Proprietary Name: RIVASTIGMINE TARTRATE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 6MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A090879
Product Number: 004
Approval Date: Jun 10, 2015
Applicant Holder Full Name: ORBION PHARMACEUTICALS PRIVATE LTD
Marketing Status: Prescription
Patent and Exclusivity Information